GAD-65 Antibody
GAD-65 Antibody is a clinical biomarker on the Autoimmune panel, reported in IU/mL. Standard reference range: 0–1 IU/mL. Functional (optimal) range used by integrative practitioners: 0–0 IU/mL.
What is GAD-65 Antibody?
GAD-65 antibodies target glutamic acid decarboxylase in pancreatic beta cells; they are a biomarker of autoimmune beta cell destruction in type 1 diabetes and LADA.
Reference ranges
| Range type | Value (IU/mL) | Source |
|---|---|---|
| Standard (lab) | 0–1 | Typical Quest / LabCorp adult reference |
| Functional (optimal) | 0–0 | Integrative / functional medicine consensus |
How SomaVue interprets GAD-65 Antibody
SomaVue maps every result for GAD-65 Antibody against four clinical lenses — nutrient cofactors, toxin exposure, infection drivers, and circadian/hormonal context — and connects each interpretation to specific peer-reviewed citations. Pre-mapped clinical reasoning and cross-marker pattern detection are available inside the practitioner workspace.
See the full interpretation
Upload a patient PDF or enter values manually to see the four-lens analysis, cross-marker patterns, and cited evidence for GAD-65 Antibody and 205 other markers.
Try it freeEducational reference only. Reference ranges vary by laboratory, assay method, age, sex, and clinical context. Functional ranges represent integrative-medicine consensus and are not regulatory thresholds. SomaVue does not diagnose, treat, mitigate, or prevent disease. Always consult a licensed healthcare provider.